Literature DB >> 6109556

Near-fatal bronchospasm after oral nadolol in a young asthmatic and response to ventilation with halothane.

J M Raine, M G Palazzo, J H Kerr, P Sleight.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6109556      PMCID: PMC1504362          DOI: 10.1136/bmj.282.6263.548

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  5 in total

1.  Cardioselective and non-cardioselective beta-blockers in reversible obstructive airways disease.

Authors:  M K Benson; W T Berrill; G M Sterling; P B Decalmer; S S Chatterjee; R S Croxson; J M Cruickshank
Journal:  Postgrad Med J       Date:  1977       Impact factor: 2.401

2.  On observing patterns of airflow obstruction in chronic asthma.

Authors:  M Turner-Warwick
Journal:  Br J Dis Chest       Date:  1977-04

Review 3.  Regulation of bronchomotor tone during anesthesia.

Authors:  D M Aviado
Journal:  Anesthesiology       Date:  1975-01       Impact factor: 7.892

4.  Severe asthma after inadvertent ingestion of oxprenolol.

Authors:  I P Williams; F J Millard
Journal:  Thorax       Date:  1980-02       Impact factor: 9.139

5.  Initial experience with a new long-acting beta-blocker, nadolol, in hypertensive patients.

Authors:  G Hitzenberger
Journal:  J Int Med Res       Date:  1979       Impact factor: 1.671

  5 in total
  22 in total

1.  Effects of hydrocortisone on acute β-adrenoceptor blocker and histamine induced bronchoconstriction.

Authors:  Philip M Short; Peter A Williamson; Brian J Lipworth
Journal:  Br J Clin Pharmacol       Date:  2012-05       Impact factor: 4.335

Review 2.  Late onset asthma.

Authors:  J G Ayres
Journal:  BMJ       Date:  1990-06-23

3.  Assessment of airways, tremor and chronotropic responses to inhaled salbutamol in the quantification of beta 2-adrenoceptor blockade.

Authors:  B J Lipworth; R A Brown; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1989-07       Impact factor: 4.335

4.  Potentially hazardous co-prescribing of beta-adrenoceptor antagonists and agonists in the community.

Authors:  J M Evans; J L Hayes; B J Lipworth; T M MacDonald
Journal:  Br J Gen Pract       Date:  1996-07       Impact factor: 5.386

5.  Extracorporeal membrane oxygenation as emergency treatment for life-threatening acute severe asthma.

Authors:  D King; C Smales; A G Arnold; O G Jones
Journal:  Postgrad Med J       Date:  1986-09       Impact factor: 2.401

Review 6.  Status asthmaticus in adults.

Authors:  H Don
Journal:  Clin Rev Allergy       Date:  1985-02

Review 7.  Adverse reactions and interactions with beta-adrenoceptor blocking drugs.

Authors:  R V Lewis; D G McDevitt
Journal:  Med Toxicol       Date:  1986 Sep-Oct

8.  Assessment of the relative safety of the beta-blockers ICI 141,292 and atenolol in patients with bronchial asthma.

Authors:  S Groth; P Tønnesen; M Asted; H Dirksen; P G Sørensen
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

9.  Absence of respiratory effects with ivabradine in patients with asthma.

Authors:  K Suresh Babu; Frantisek Gadzik; Stephen T Holgate
Journal:  Br J Clin Pharmacol       Date:  2008-03-13       Impact factor: 4.335

10.  Halothane treatment in life-threatening asthma.

Authors:  P Rosseel; L F Lauwers; L Baute
Journal:  Intensive Care Med       Date:  1985       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.